SEC Filings

Filing date	Form	Description	Filing Group	View
February 3, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-010230.pdf 0001104659-23-010230.rtf 0001104659-23-010230.xls
February 2, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-009560.pdf 0001104659-23-009560.rtf 0001104659-23-009560.xls
January 25, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-006384.pdf 0001104659-23-006384.rtf 0001104659-23-006384.xls
January 25, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-006388.pdf 0001104659-23-006388.rtf
January 20, 2023	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Registration Statements	View HTML 0001104659-23-005236.pdf 0001104659-23-005236.rtf 0001104659-23-005236.xls
January 19, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-000560.pdf 0000000000-23-000560.rtf
January 13, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-003636.pdf 0001104659-23-003636.rtf 0001104659-23-003636.xls
January 13, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-003637.pdf 0001104659-23-003637.rtf
January 6, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-000192.pdf 0000000000-23-000192.rtf
December 28, 2022	F-4	Registration statement for foreign private issuers issued in certain business transactions	Registration Statements	View HTML 0001104659-22-130315.pdf 0001104659-22-130315.rtf 0001104659-22-130315.xls

Data provided by Kaleidoscope.

Print Page

Email Alerts

RSS Feeds

Contact IR

Site Map Terms of Use Privacy

Contact Info

YS Biopharma Co., Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +1 (301) 208 8823
Fax: +1 (301) 208 8827

bjinfo@yishengbio.com